ストックスクリーナーアプリを入手
59.80
0.05%
0.03
アフターアワーズ：
59.80
前日終値:
$59.77
開ける：
$59.8
24時間の取引高:
1.29M
Relative Volume:
0.78
時価総額：
$2.33B
収益：
-
当期純損益:
$-76.34M
株価収益率:
-23.44
EPS:
-2.5513
ネットキャッシュフロー:
$-65.93M
1週間 パフォーマンス:
+0.18%
1か月 パフォーマンス:
+0.67%
6か月 パフォーマンス:
+203.09%
1年 パフォーマンス:
+1,359%
1日の値動き範囲:
$59.77
$59.83
1週間の範囲:
$59.68
$59.85
52週間の値動き範囲:
$3.60
$59.95
Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile
名前
Longboard Pharmaceuticals Inc
セクター
電話
619-592-9775
住所
4275 EXECUTIVE SQUARE, LA JOLLA
LBPH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| LBPH | 59.80 | 2.33B | 0 | -76.34M | -65.93M | -2.5513 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-04-27 | 開始されました | B. Riley Securities | Buy |
| 2021-04-07 | 開始されました | Evercore ISI | Outperform |
| 2021-04-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-04-06 | 開始されました | Citigroup | Buy |
| 2021-04-06 | 開始されました | Guggenheim | Buy |
すべてを表示
Longboard Pharmaceuticals Inc (LBPH) 最新ニュース
Jennison Associates LLC Sells 34,440 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MARX, BRKH, MNTX and LPBH - GlobeNewswire Inc.
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage - MSN
299,156 Shares in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Bought by Braun Stacey Associates Inc. - MarketBeat
LBPHLongboard Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs) - Business Wire
Longboard Pharma Launches Groundbreaking Phase 3 Trial for Rare Epilepsy Treatment | LBPH Stock News - StockTitan
Longboard Pharmaceuticals Advances Neurological Treatments - TipRanks
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
FMR LLC Reduces Stake in Longboard Pharmaceuticals Inc - GuruFocus.com
Longboard Pharma Reports Strong Q3, Advances Phase 3 Trial Amid Lundbeck Acquisition Deal | LBPH Stock News - StockTitan
How the (LBPH) price action is used to our Advantage - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World
Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com South Africa
Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat
500: Something went wrong - Investing.com
Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts - Defense World
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN
(LBPH) Trading Signals - Stock Traders Daily
B. Riley Offloads Great American To Oaktree To Cut Debt - Finimize
Longboard Pharmaceuticals stock soars to all-time high of $59.48 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Longboard Pharmaceuticals stock soars to all-time high of $59.48 - Investing.com India
$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
The week in pharma: action, reaction and insight – week to October 19 | Pharmaceutical | The Pharmaletter - The Pharma Letter
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MSN
Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion. - MSN
Longboard soars as Lundbeck to buy company for equity value of $2.6B - MSN
Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck - MSN
SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - MSN
Taxation With Representation: Baker, Simpson, Ropes - Law360
Pα+ Psychedelic Bulletin #177: Bright Minds Surges on Longboard’s Seizure Drug Success; Kasvu Therapeutics Is Developing Psychoplastogens With a TrkB Twist - Psychedelic Alpha
HC Wainwright Reiterates Neutral Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - Defense World
Longboard Pharmaceuticals CMO sells $983,936 in stock By Investing.com - Investing.com South Africa
Randall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Stock - MarketBeat
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Malaysian Reserve
Longboard Pharmaceuticals (NASDAQ:LBPH) Lowered to Hold at Wedbush - MarketBeat
Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% - MSN
Lundbeck's billion-dollar acquisition will cost layoffs - MedWatch
Lundbeck to Acquire Longboard Pharmaceuticals - CHEManager
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals - Global Legal Chronicle
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update - MarketBeat
Longboard Pharmaceuticals Inc (LBPH) 財務データ
収益
当期純利益
現金流量
EPS
Longboard Pharmaceuticals Inc (LBPH) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lind Kevin Robert | CEO |
Nov 13 '24 |
Option Exercise |
3.12 |
12,808 |
40,002 |
443,740 |
| Kaye Randall | CMO |
Oct 15 '24 |
Option Exercise |
4.35 |
16,667 |
72,501 |
34,587 |
| Kaye Randall | CMO |
Oct 15 '24 |
Sale |
59.03 |
16,667 |
983,936 |
17,920 |
| Kaye Randall | CMO |
Sep 16 '24 |
Option Exercise |
4.35 |
16,666 |
72,497 |
34,586 |
| Kaye Randall | CMO |
Sep 16 '24 |
Sale |
31.64 |
16,666 |
527,318 |
17,920 |
1.89%
2.08%
大文字化:
|
ボリューム (24 時間):